The distinguished translational oncology researchers on Unum’s Scientific Advisory Board (SAB) provide counsel to support continued development of our ACTR platform, and provide us with key insights as we develop our broader research agenda. Comprised of pioneers in immuno-oncology, our SAB includes:
Dario Campana, MD, PhD
Malcom Brenner, MD, PhD
John Gribben, MD, DSc, FRCP, FRCPath, FMedSci
Crystal Mackall, MD
Crystal L. Mackall, MD
Dr. Mackall is currently Professor of Pediatrics and of Medicine at the Stanford University School of Medicine. She additionally serves as associate director of the Stanford Cancer Institute, co-medical director of the Stanford Laboratory for Cell and Gene Medicine, and as program leader in pediatric cancer immunotherapy. Much of her career was spent at the National Cancer Institute, where she served as Head of Immunology Section and Chief of the Pediatric Oncology Branch. Her work focuses on translational research and immunotherapy for childhood cancers. An expert in the field of T cell homeostasis, Dr. Mackall has experience leading clinical trials of engineered T cell and Natural Killer cell therapies. She also co-leads the StandUp2Cancer/St.Baldrick’s/NCI Pediatric Dream Team.